A method for preparing controllable degradable magnesium alloy materials

By injecting copper ions to form a structural defect layer, a nano-fine grain layer, and a strain coarse grain layer on the surface of magnesium alloy, the problems of uneven degradation and coating peeling of magnesium alloy staples in vivo were solved, achieving controllable degradation and antibacterial properties, and meeting the multi-stage healing requirements of gastrointestinal anastomosis.

CN118808360BActive Publication Date: 2026-11-10CHINA WEAPON SCI ACADEMY NINGBO BRANCH
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410877233.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-07-02
Publication Date
2026-11-10
Estimated Expiration
2044-07-02

AI Technical Summary

Technical Problem

Existing magnesium alloy staples degrade unevenly in vivo, failing to meet the mechanical requirements of different healing stages. Furthermore, the coating preparation process suffers from the use of toxic solvents and poor interfacial adhesion, making it unable to effectively inhibit local infection.

Method used

By implanting copper ions into the surface of magnesium alloys, a modified layer consisting of a structural defect layer, a nano-fine grain layer, and a strained coarse grain layer is formed. By controlling the release rate of copper ions with specific process parameters, the controllable degradation and antibacterial properties of magnesium alloys can be achieved.

Benefits of technology

It enables the controlled degradation of magnesium alloy materials at different healing stages, provides appropriate mechanical support and antibacterial properties, reduces the incidence of anastomotic leakage, and avoids coating peeling and the use of toxic solvents.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118808360B_ABST
    Figure CN118808360B_ABST
Patent Text Reader

Abstract

This invention discloses a method for preparing a controllable degradable magnesium alloy material, comprising the following steps: Cleaning: ultrasonically cleaning the magnesium alloy after removing the surface oxide film; Alloy melting: melting the cleaned magnesium alloy in step one under an inert atmosphere to obtain a molten alloy, and cooling to obtain a cast magnesium alloy; Extruded alloy preparation: firstly, homogenizing heat treatment is performed on the cast alloy obtained in step two, and then extruding to obtain an extruded magnesium alloy; Wire preparation: annealing the extruded alloy obtained in step three, and then performing multiple drawing passes to obtain magnesium alloy wire; Ion implantation: cutting the wire, grinding and cleaning the wire, and performing copper ion implantation on a metal ion implanter equipped with a copper cathode arc source to obtain a controllable degradable magnesium alloy material. Compared with the prior art, the magnesium alloy material prepared by this invention provides mechanical support and antibacterial properties in the early stage of healing, degrades appropriately and slowly in the middle stage, and degrades at a relatively rapid rate in the later stage to avoid inducing inflammation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of biometallic materials, specifically to a method for preparing controllable degradable magnesium alloy materials. Background Technology

[0002] In gastrointestinal anastomosis, the use of staplers can shorten the operation time, reduce postoperative complications, and alleviate patient suffering. However, currently commonly used surgical staples are non-degradable and remain permanently in the body, easily causing adverse reactions such as allergic reactions, foreign body reactions, and tissue adhesions. Magnesium and magnesium alloys, with their good biocompatibility and mechanical properties, as well as their ability to degrade and be absorbed in the human environment, are considered potential candidates for biodegradable staple materials. Complete healing after gastrointestinal anastomosis generally takes 30–40 days. Histologically, the gastrointestinal healing process can be roughly divided into three stages: the early stage (1–3 days) is the mechanical healing stage; the middle stage (4–15 days) is the biochemical healing stage; and the late stage (after 15 days) is the wound maturation stage. In the mechanical healing stage, from the moment the gastrointestinal tissue is cut, an inflammatory response occurs at the wound site, clearing microorganisms from the surrounding area. Simultaneously, macrophages induce lymphocytes to release interleukins and interferons, producing vascular endothelial growth factor to promote angiogenesis, and the wound begins to heal. At this time, the wound mainly relies on the staples for mechanical support. During the biochemical healing phase, perivascular stromal cells secrete the matrix and nutrients necessary for wound healing. Fibroblasts and smooth muscle migrate to the wound site. Approximately two weeks after anastomosis, fibroblast proliferation reaches its peak, generating new capillaries, and the wound's tensile strength rapidly increases. In the postoperative wound maturation phase, the connective tissue at the wound site gradually matures, the number of macrophages and fibroblasts decreases, the intestinal epithelium largely recovers, and the wound's tensile strength further strengthens. Three weeks post-surgery, the wound's tensile strength recovers to approximately 70% of its initial value.

[0003] The mechanical requirements of implanted anastomotic staples vary at different stages of gastrointestinal healing. Therefore, controlled degradation of the implanted staples is required. Specifically, they should degrade slowly in the early stage of wound healing to provide sufficient mechanical support; degrade uniformly at an appropriate rate in the middle stage of implantation to release beneficial ions that promote endothelial cell proliferation, synthesis, and new blood vessel formation at the wound site, thus enabling the wound to withstand pressure; and in the later stage of implantation, when morphological healing of the wound is complete, the staples need to degrade rapidly and uniformly at an appropriate rate to avoid side effects such as anterior rectal resection syndrome caused by residual implanted staples.

[0004] Furthermore, clinical studies have found that the incidence of anastomotic leakage after colorectal resection ranges from 3% to 20%, with the incidence of leakage at low rectal or colonic-anal anastomoses reaching as high as 24%. Severe peritonitis caused by anastomotic leakage can even be life-threatening. Factors contributing to anastomotic leakage include surgical anastomosis technique, local infection at the anastomosis site, and excessive tension after anastomosis. Among these, local infection is one of the most common factors causing anastomotic leakage and can affect the healing process in the mid-to-late stages after gastrointestinal anastomosis. Studies have found that commensal bacteria in the human gut, such as Enterococcus faecalis, Pseudomonas aeruginosa, and Serratia marcescens, can transform into highly virulent pathogens due to the inflammatory environment created by the post-anastomosis inflammatory response. These pathogens produce proteases that dissolve the extracellular matrix, leading to anastomotic leakage. Therefore, inhibiting certain bacterial flora at the anastomosis site can significantly reduce the incidence of anastomotic leakage.

[0005] The aforementioned issues necessitate controlled degradation and resistance to local infection in intra-articular anastomotic staple implants. Specifically, the implant should degrade slowly in the early stages of wound healing to provide sufficient mechanical support, degrade uniformly in the middle stages to promote healing, and degrade rapidly and uniformly in the later stages, achieving a degradation rate that matches the tissue healing rate. The implant should be completely degraded when the tissue is fully healed. Furthermore, during wound healing, it should inhibit some bacterial colonies at the anastomosis site to prevent anastomotic leakage.

[0006] The published Chinese invention patent, "A Biodegradable Antibacterial Magnesium Alloy Anastomotic Nail and Its Preparation Method" (Publication No.: CN 117018300 A), describes a method for preparing a magnesium alloy wire with antibacterial and acid / alkali resistance by impregnation, spraying, or hydrothermal synthesis of a mixture of bio-polysaccharides and their derivatives with black phosphorus. However, the coating preparation process uses N-dimethylformamide organic solvent, which is toxic and long-term exposure can affect the nerves, liver, and skin, and may even be carcinogenic. This coating preparation process does not conform to the current market's pursuit of green and environmentally friendly practices. Furthermore, when the anastomotic nail is used, the tail is subjected to bending forces, causing the coating on the nail surface to easily bulge or even crack and fail. This patent does not consider the problem of the coating peeling off from the substrate under stress.

[0007] Chinese invention patent "A Magnesium Alloy Surface Coating Material and Its Application" (application publication number CN114481074A) describes a method for depositing a DLC coating on a magnesium alloy using magnetron sputtering under an argon atmosphere. The coating material is then annealed and implanted with titanium in an ion implantation device to improve the corrosion resistance of medical magnesium alloys in simulated body fluids. This patent employs a two-stage deposition process to prepare the corrosion-resistant coating, resulting in high production costs, slow production efficiency, and complex operation. Furthermore, the degradation rate of the prepared magnesium and magnesium alloy is uniform, failing to meet the requirements for graded degradation of implantable devices. There is a need to develop an ion implantation surface modification process technology that is simple to operate and can achieve graded degradation of magnesium and magnesium alloys.

[0008] Chinese invention patent "A Method for Preparing an Antibacterial Coating on the Surface of Magnesium and Magnesium Alloys" (application publication number CN114369808A) utilizes a double-layer glow discharge plasma deposition equipment to deposit Cu elements on the surface of a magnesium / magnesium alloy substrate. This creates a Mg2Cu gradient distribution in the diffusion layer on the alloy surface, enabling the gradient release of Cu ions to address infections at different stages, such as early and delayed postoperative infections. High temperature is a characteristic of double-layer glow discharge plasma deposition technology, making it suitable for alloying high-melting-point metals like iron-based metals. However, magnesium and magnesium alloys have low melting points, and the substrate structure and properties are easily altered at such high temperatures. Lower-temperature sputtering often results in poor deposition effects and thinner layers, typically forming a deposition layer and a thin diffusion layer on the alloy surface. The ability of a thin Cu ion diffusion layer to inhibit microbial infection is limited.

[0009] Methods for regulating the degradation behavior of medical magnesium alloy staples and endowing them with biomedical functions include severe plastic deformation of the surface and surface coating preparation. However, the impact of severe plastic deformation processes on magnesium and the corrosion behavior of magnesium alloys remains highly controversial, and process parameters need to be explored to achieve optimal degradation rates and mechanical properties. Coating is one of the commonly used methods for surface modification. Currently, the main methods for preparing coatings for staple surfaces include impregnation, spraying, or hydrothermal synthesis. However, these methods suffer from poor interfacial adhesion to the substrate, and problems such as peeling and degradation under stress need to be solved. In addition, due to the addition of organic solvents, long-term contact can easily cause adverse effects on nerves, liver, and skin, and the preparation of this coating through a solution medium does not conform to the current market's pursuit of green and environmentally friendly production. Summary of the Invention

[0010] The technical problem to be solved by the present invention is to provide a method for preparing controllable degradable magnesium alloy materials in light of the above-mentioned technical status. The method has simple steps, and the prepared magnesium alloy materials are degradable, have good antibacterial properties, and can be used in the field of gastrointestinal anastomosis nails, which meets the requirements for controllable degradation of medical metal materials for in vivo implantation.

[0011] The technical solution adopted by this invention to solve the above-mentioned technical problems is: a method for preparing controllably degradable magnesium alloy materials, characterized by comprising the following steps:

[0012] Step 1, Cleaning: Remove the surface oxide film of the magnesium alloy with phosphoric acid solution and then ultrasonically clean it;

[0013] Step 2, Alloy Melting: Melt the magnesium alloy cleaned in Step 1 under an inert atmosphere to obtain a molten alloy, and cool it to obtain a cast magnesium alloy;

[0014] Step 3, preparation of extruded alloy: First, the cast alloy obtained in Step 2 is subjected to homogenization heat treatment, and then extruded to obtain extruded magnesium alloy;

[0015] Step 4, wire preparation: The extruded alloy obtained in Step 3 is annealed and then drawn in multiple passes to obtain magnesium alloy wire.

[0016] Step 5, Ion Implantation: Cut the wire, grind and clean the wire, and perform copper ion implantation on a metal ion implanter equipped with a copper cathode arc source to obtain a controllable degradable magnesium alloy material; the surface of the controllable degradable magnesium alloy material has a modified layer, which is provided with a structural defect layer, a nano-fine grain layer and a strain coarse grain layer from the surface inward.

[0017] Cu 2+ A concentration of 65–650 mg / L is sufficient to kill 99% of Staphylococcus aureus and Pseudomonas aeruginosa, and it has no cytotoxic effect on fibroblasts. 2+ Concentration ≥10 -5 At a concentration of mol / L, it has a bactericidal effect against Pseudomonas aeruginosa and Enterococcus faecalis. Therefore, introducing Cu into gastrointestinal anastomotic staples, allowing it to release Cu ions during wound healing, can significantly reduce the incidence of anastomotic leakage caused by local infection from common intestinal bacteria such as Pseudomonas aeruginosa and Enterococcus faecalis.

[0018] Preferably, in step five, the magnesium alloy wire implanted with copper ions is placed on the water-cooled target of the metal ion implanter, the ion implantation angle is 7–10°, the accelerating voltage is 40–50 kV, and the vacuum chamber pressure is 2.0–6.0 × 10⁻⁶ kV. -4 The implanted beam current is 1.0–2.0 mA; the copper ion implantation dose is 0.8–3 × 10⁻⁶. 17 ion / cm 2 .

[0019] Placing the filament on the water-cooled target ensures a relatively low sample deposition temperature, thus preventing changes in the sample substrate structure and properties due to excessively high temperatures during ion implantation.

[0020] The purpose of tilting the ion implantation angle is to misalign the ion incident direction with the lattice channel, reducing channeling effects and ensuring uniform ion implantation depth. If the tilt angle is too large, ions are partially blocked, forming a large shadow area, causing a deviation between the actual implanted area and the designed area. If the tilt angle is too small, it cannot effectively solve the channeling effect and can easily cause a bimodal distribution. A common practice to avoid channeling effects is to set the implantation angle between 7 and 10° to the crystal plane normal. This helps to disrupt the ion path, reduce the probability of ions penetrating along the channel, ensure the ion implantation depth, and reduce the shadowing effect of ion implantation.

[0021] The accelerating voltage determines the depth and shape of the implanted ions. As the accelerating voltage increases, the ion implantation depth increases, but the dispersion of the implantation trajectory decreases. Considering the uniformity of ion implantation, an implantation depth of 1–3 μm on the magnesium alloy surface, i.e., an accelerating voltage between 40–50 kV, is most suitable.

[0022] The entire ion implantation process must be carried out under high vacuum to reduce the probability of collisions between charged ions and neutral gas molecules along the ion trajectory. Collisions cause ion scattering and loss, and unwanted ions are generated during charge exchange between ions and neutral atoms, resulting in radiation contamination. To avoid radiation contamination, the vacuum level should be on the order of 10⁻⁴ Pa. If the vacuum level is too low, on the one hand, the beam current of the implanter will be relatively small, resulting in a slower implantation speed; on the other hand, it will lead to poor ion beam focusing, insufficient implantation purity, and poor uniformity of ion implantation depth. The higher the vacuum level, the straighter the electron beam path and the higher the energy reaching the sample surface. However, higher energy results in deeper implantation depth, meaning a lower implantation concentration. Experimental exploration has found that the optimal pressure of the vacuum chamber is 2.0–6.0 × 10⁻⁴ Pa. -4 pa.

[0023] The injection beam current determines the scan time. Increasing the current shortens the scan time, increases the injection capacity, and also increases the number of impurity atoms injected per unit time, leading to poorer injection uniformity. Insufficient current results in a low injection rate, affecting injection efficiency. Experimental results show that the suitable injection rate range is 1.0–2.0 mA.

[0024] The injection dose is the total number of ions injected per unit area of ​​the sample surface, expressed in ions per square centimeter. The injection dose formula is as follows:

[0025]

[0026] Where I is the beam current in amperes, t is the injection time in seconds, and q is the electron charge, equal to 1.6 × 10⁻⁶. -19 n is the charge of each ion, and A is the injection area in cm². 2 .

[0027] The implantation dose determines the implantation depth. Exceeding a certain dose can introduce point defects such as vacancies and interstitial atoms into the substrate, which can then recombine to form dislocations. When high-energy ions are implanted into the alloy surface, they cause lattice distortion in the matrix, hindering dislocation movement and thus strengthening the alloy. Experiments have shown that after ion implantation exceeds a certain value, the surface hardness of magnesium alloys no longer increases monotonically but exhibits a trend of first decreasing and then increasing. Furthermore, excessive ion implantation can cause more surface defects. The sputtering effect produced by ion implantation alters the surface roughness of magnesium alloys. Experimental results show that the surface roughness of magnesium alloys initially decreases and then increases with increasing implantation dose. Generally, the smoother the alloy surface, the better its corrosion resistance and mechanical properties. To obtain magnesium alloys with optimal corrosion resistance and mechanical properties, the most suitable Cu implantation dose is 0.8–3 × 10⁻⁶. 17 ion / cm 2 .

[0028] Preferably, step one involves removing the surface oxide film by acid washing with a phosphoric acid solution with a volume fraction of 5-8%.

[0029] Preferably, the extrusion temperature in step three is 200–250°C, the extrusion speed is 9–11 mm / s, and the extrusion ratio is 54:1–64:1. This extrusion temperature can largely prevent dynamic recrystallization during deformation, which would result in coarse grains, while a large extrusion ratio is beneficial for strengthening plastic deformation.

[0030] Preferably, the magnesium alloy in step one is one or more of Mg, Mg-Zn, Mg-Mn, and Mg-Zn-Mn alloys.

[0031] Preferably, the magnesium alloy has a Mg content ≥ 98 wt.%.

[0032] Preferably, step two involves: melting the magnesium alloy cleaned in step one using an induction furnace and a graphite crucible under CO2 and SF6 protection to obtain a molten alloy; pouring the molten alloy into a dry low-carbon steel mold with BN coating on the inner wall, and cooling to obtain a cast magnesium alloy. The low-carbon steel is carbon steel with a carbon content of less than 0.25%.

[0033] To achieve a gradient structure on the surface of the magnesium alloy material for graded degradation, preferably, the surface of the controllable degradable magnesium alloy material has a modified layer. This modified layer, from the surface inwards, comprises a structural defect layer, a nanocrystalline layer, and a strained coarse-grained layer. The thickness of the modified layer is 1.5–2.1 μm. The outermost region of the modified layer is a structural defect layer with a depth of approximately 50–80 nm; the next outermost region is a nanocrystalline layer with a thickness of approximately 550–620 nm; and the innermost layer is a coarse-grained strained layer. This region has relatively large grain sizes and contains many fine precipitates and dislocations. The structural defects in the outermost region, caused by ion implantation, accelerate degradation. Furthermore, the uniform distribution of Cu elements on the surface layer due to ion implantation significantly suppresses galvanic corrosion, resulting in a uniform corrosion degradation mode.

[0034] Preferably, the thickness of the structural defect layer is 50–80 nm; the thickness of the nanocrystalline layer is 550–620 nm; and the thickness of the strained coarse-grained layer is 870–1430 nm. This thickness range is optimal for the structural defect layer, ensuring a uniform release of Cu ions in the outermost region during the initial soaking stage, significantly inhibiting preoperative bacterial infection and preventing oral leakage during anastomosis. It also prevents excessive degradation of the implant, which would otherwise fail to provide sufficient mechanical support. The nanocrystalline layer, due to its nanostructure and low phase interface, enhances the alloy's corrosion resistance. Simultaneously, the surface layer contains highly corrosion-resistant materials such as CuO and MgO, forming a corrosion-inhibiting barrier that ensures slow degradation during the mid-implantation stage to provide the mechanical support needed for wound healing. The degradation cycle of the 550–620 nm thick subsurface region perfectly matches the mid-healing stage after gastrointestinal anastomosis.

[0035] Preferably, the grain size of the structural defect layer is 500–580 nm; the grain size of the nanocrystalline region is 250–300 nm; and the grain size of the strain-coarse-grained region is 600–750 nm. The strain-coarse-grained layer has a relatively large grain size and contains many fine precipitates and dislocations; the average strain accumulation is higher, but the strain difference between different grains is reduced. Therefore, the strain-coarse-grained layer region will degrade in a larger and more uniform manner in the later stages of implantation, achieving rapid degradation at an appropriate rate in the later stages of implantation and avoiding side effects such as inflammation and scarring caused by implant residue.

[0036] Preferably, the annealing temperature in step four is 280-300℃.

[0037] Compared with the prior art, the advantages of the present invention are as follows:

[0038] ① Adding copper can refine the microstructure of magnesium alloys, enhance mechanical properties, and improve the degradation behavior of magnesium alloys. In addition, Cu is an important factor in wound healing, promoting and inducing angiogenesis and stimulating endothelial cell proliferation. Moreover, Cu has excellent antibacterial properties, thus avoiding the risk of anastomotic leakage in gastrointestinal anastomosis surgery caused by common gastrointestinal bacteria such as Pseudomonas aeruginosa and Enterococcus faecalis in the prepared magnesium alloy materials.

[0039] ② Ion implantation can introduce beneficial copper elements into the sample surface, providing complete mechanical support for the implanted device during tissue healing. Ion implantation will cause structural defects to form on the outermost layer of the magnesium alloy. Cu ions in the structural defect layer are released rapidly and uniformly in the early stage, while the finer nanocrystalline layer forms copper oxide due to ion implantation, which inhibits corrosion and reduces the degradation rate. This makes its degradation rate lower than that of the outermost structural defect layer and the innermost strain coarse-grained layer, meeting the requirements for controllable degradation of medical metal materials for in vivo implantation. That is, it is required to provide sufficient mechanical support and antibacterial properties before the injured tissue heals, degrade slowly and uniformly in the middle of healing, and degrade at an appropriately fast rate in the later stage of healing to avoid inducing side effects such as inflammation. Attached Figure Description

[0040] Figure 1 These are schematic diagrams of alloy melting in various embodiments of the present invention;

[0041] Figure 2 These are schematic diagrams of hot extrusion in various embodiments of the present invention;

[0042] Figure 3 These are schematic diagrams of ion implantation in various embodiments of the present invention;

[0043] Figure 4 This is a schematic diagram of the in vitro antibacterial experiments of various embodiments of the present invention. Detailed Implementation

[0044] The present invention will be further described in detail below with reference to the accompanying drawings and embodiments.

[0045] Unless otherwise specified, all reagents and materials used in the embodiments are commercially available.

[0046] Example 1

[0047] A method for preparing a controllable degradable magnesium alloy material includes the following steps:

[0048] 1) Cleaning: Remove the surface oxide film of pure Mg and Mg-50wt.%Zn master alloy with 6% phosphoric acid solution, and then place it in anhydrous ethanol for ultrasonic cleaning to remove the oxide layer, dust and oil stains on the material surface.

[0049] 2) Alloy melting: The magnesium alloy cleaned in step one was melted sequentially using an induction furnace and a graphite crucible under an inert atmosphere of CO2 and SF6. The prepared molten alloy was poured into a dry low-carbon steel mold with BN coating on the inner wall, and cooled to obtain a cast Mg-0.5wt.%Zn alloy. The alloy melting process is detailed below. Figure 1 .

[0050] 3) Preparation of extruded alloy: First, the as-cast alloy obtained in step two is subjected to homogenization heat treatment. Then, the surface of the as-cast alloy is polished with a grinding wheel to remove oil, burrs, and oxide film. Finally, an extruded Mg-0.5wt.%Zn alloy is prepared at 220℃, at a speed of 10mm / s, and an extrusion ratio of 64:1. The alloy extrusion process is described in [link to extrusion process]. Figure 2 .

[0051] 4) Wire preparation: The extruded alloy obtained in step 3) is annealed at 290℃ and then drawn in multiple passes at room temperature to obtain wire a with a diameter of 0.3 to 0.7 mm.

[0052] 5) Ion Implantation: The filament a obtained in step 4) was sequentially ground with SiC sandpaper of different grits, ultrasonically cleaned with alcohol for 10 min, and then dried in air. Cu ions were implanted into a metal ion implanter equipped with a Cu cathode arc source to obtain controllably degradable magnesium alloy material. The Cu ion implantation angle was 7°, the accelerating voltage was 40 kV, and the vacuum chamber pressure was 2.0 × 10⁻⁶. -4 The implantation beam current was 1.0 mA, and the Cu ion implantation dose was 0.8 × 10⁻⁶. 17 ion / cm 2 The ion injection process is described in [link to ion injection procedure]. Figure 3 In this process, diffusion pump 2 removes the gas inside the ion implanter to achieve a high vacuum state; wire a is placed on the rotary table 1, ion source 4 generates the required copper ions, and ion beam 3 is uniformly injected into wire a.

[0053] Example 2

[0054] A method for preparing a controllable degradable magnesium alloy material includes the following steps:

[0055] 1) Cleaning: Remove the surface oxide film of pure Mg and Mg-15wt.%Mn master alloy with 6% phosphoric acid solution, and then place it in anhydrous ethanol for ultrasonic cleaning to remove the oxide layer, dust and oil stains on the surface of the material.

[0056] 2) Alloy melting: The sample from step 1) was melted sequentially using an induction furnace and a graphite crucible under an inert atmosphere of CO2 and SF6. Then, the prepared molten alloy was poured into a pre-dried low-carbon steel mold with BN coating on the inner wall, and cooled to obtain a cast Mg-1wt.%Mn alloy.

[0057] 3) Preparation of extruded alloy: First, the cast alloy obtained in step 2) is subjected to homogenization heat treatment. Then, the surface of the cast alloy is polished with a grinding wheel to remove oil, burrs, and oxide film from the sample surface. Finally, an extruded Mg-1wt.%Mn alloy is prepared at 220℃ at a speed of 10mm / s and an extrusion ratio of 64:1.

[0058] 4) Wire preparation: The extruded alloy obtained in step 3) is annealed at 290°C and then drawn in multiple passes at room temperature to obtain wire with diameters of 0.3 to 0.7 mm.

[0059] 5) Ion Implantation: The filament obtained in step 4) was sequentially ground with SiC sandpaper of different grits, ultrasonically cleaned with alcohol for 10 minutes, and then dried in air. Cu ions were implanted into a metal ion implanter equipped with a Cu cathode arc source to obtain controllably degradable magnesium alloy material. The ion implantation angle was 10°, the accelerating voltage was 50 kV, and the vacuum chamber pressure was 4.0 × 10⁻⁶. - 4 The implantation beam current was controlled at 2.0 mA. The Cu ion implantation dose was 1.5 × 10⁻⁶. 17 ion / cm 2 .

[0060] Example 3

[0061] A method for preparing a controllable degradable magnesium alloy material includes the following steps:

[0062] 1) Cleaning: Remove the surface oxide film of pure Mg, Mg-50wt.%Zn and Mg-15wt.%Mn master alloys with 6% phosphoric acid solution, and then place them in anhydrous ethanol for ultrasonic cleaning to remove the oxide layer and attached dust and oil on the material surface.

[0063] 2) Alloy melting: Weigh the sample obtained in step 1) according to the designed composition. Melt the sample from step 1) sequentially using an induction furnace and a graphite crucible under an inert atmosphere of CO2 and SF6. Then, pour the prepared molten alloy into a pre-dried low-carbon steel mold with BN coating on the inner wall, and cool to obtain a cast Mg-0.5wt.%Zn-1wt.%Mn alloy.

[0064] 3) Preparation of extruded alloy: First, the cast alloy obtained in step 2) is subjected to homogenization heat treatment. Then, the surface of the cast alloy is polished with a grinding wheel to remove oil, burrs, and oxide film from the sample surface. Finally, an extruded Mg-0.5wt.%Zn-1wt.%Mn alloy is prepared at 220℃ at a speed of 10mm / s and an extrusion ratio of 64:1.

[0065] 4) Wire preparation: The extruded alloy obtained in step 3) is annealed at 290°C and then drawn in multiple passes at room temperature to obtain wire with diameters of 0.3 to 0.7 mm.

[0066] 5) Ion Implantation: The filament obtained in step 4) was sequentially ground with SiC sandpaper of different grits, ultrasonically cleaned with alcohol for 10 minutes, and then dried in air. Cu ions were implanted into a metal ion implanter equipped with a Cu cathode arc source to obtain controllably degradable magnesium alloy material. The ion implantation angle was 10°, the accelerating voltage was 50 kV, and the vacuum chamber pressure was 6.0 × 10⁻⁶. - 4 The implantation beam current was controlled at 2.0 mA. The Cu ion implantation dose was 3 × 10⁻⁶. 17 ion / cm 2 .

[0067] Comparative Example

[0068] 1) Cleaning: Remove the surface oxide film of pure Mg, Mg-50wt.%Zn and Mg-10wt.%Mn master alloys with 6% phosphoric acid solution, and then place them in anhydrous ethanol for ultrasonic cleaning to remove the oxide layer and attached dust and oil on the material surface.

[0069] 2) Alloy melting: Weigh the sample obtained in step 1) according to the designed composition. Melt the sample from step 1) sequentially using an induction furnace and a graphite crucible under an inert atmosphere of CO2 and SF6. Then, pour the prepared molten alloy into a pre-dried low-carbon steel mold with BN coating on the inner wall, and cool to obtain a cast Mg-0.5wt.%Zn-1wt.%Mn alloy.

[0070] 3) Preparation of extruded alloy: First, the cast alloy obtained in step 2) is subjected to homogenization heat treatment. Then, the surface of the cast alloy is polished with a grinding wheel to remove oil, burrs, and oxide film from the sample surface. Finally, an extruded Mg-0.5wt.%Zn-1wt.%Mn alloy is prepared at 220℃ at a speed of 10mm / s and an extrusion ratio of 64:1.

[0071] 4) Wire preparation: The extruded alloy obtained in step 3) is annealed at 290°C and then drawn in multiple passes at room temperature to obtain wire with diameters of 0.3 to 0.7 mm.

[0072] The surface modified layer thickness was tested in the three examples. Degradation performance, antibacterial properties, and biocompatibility were also tested in the three examples and one comparative example. The surface modified layer thickness test method was as follows: The three examples were prepared into electron microscopy (EM) samples using a thermal mounting method, then progressively polished with metallographic sandpaper up to 2000#, and finally polished to a mirror finish using a 2.5 μm polishing compound. After cleaning the EEM samples with anhydrous ethanol, the thickness of the surface modified layer was obtained using a field emission scanning electron microscope equipped with an energy dispersive spectroscopy (EDS) spectrometer.

[0073] The surface modification layer thickness of the obtained examples was tested, and the degradation performance, antibacterial properties and biocompatibility of the examples and comparative examples were tested. The test results are shown in Table 1.

[0074] Method for testing the thickness of the modified layer: Samples from the three examples were prepared for electron microscopy using a thermal mounting method. They were then progressively polished with metallographic sandpaper up to 2000#, followed by polishing to a mirror finish using a 2.5μm polishing compound. After cleaning the samples with anhydrous ethanol, the thickness of the surface modified layer was obtained using a field emission scanning electron microscope equipped with an energy dispersive spectroscopy (EDS) instrument. Furthermore, the grain size of the structural defect layer in Examples 1-3 was measured to be 500–580 nm; the grain size of the nanocrystalline region was 250–300 nm; and the grain size of the strained coarse-grained region was 600–750 nm.

[0075] Degradation performance test: Corrosion immersion test was conducted according to ASTM G31-72 standard, using simulated body fluid as the immersion solution. Detailed composition of the simulated body fluid is shown in Table 2. The samples were ultrasonically cleaned with deionized water and anhydrous ethanol, dried, and weighed. The samples were weighed at 0.05 cm... 2 The soaking ratio of / mL was suspended in centrifuge tubes by a thin thread and placed in a 37°C incubator. After soaking for different times, the samples were removed, first ultrasonically cleaned with deionized water, and then placed in a 200g·L⁻¹ solution. -1 The samples were ultrasonically cleaned in CrO3 to remove corrosion products, then rinsed with deionized water, dried, and weighed. Each immersion experiment had three parallel samples. The average corrosion rate was calculated from these three parallel samples after removing corrosion products. The formula for calculating the corrosion rate using the immersion weight loss method is as follows:

[0076]

[0077] Where CR is the corrosion rate (mm·year) -1 The coefficient K = 8.76 × 10 4 Δm is the mass loss (g), and ρ is the material density (g / cm³). 2 A is the initial surface area of ​​the immersed sample (cm²). 2 ), where t is the soaking time (h).

[0078] Antibacterial test: *Pseudomonas aeruginosa* was selected as the experimental strain to study the antibacterial properties of the material, and Luria Bertani (LB) medium was used. First, LB medium containing 15–20 g of agar was poured into an Erlenmeyer flask and sterilized at high temperature. Then, an alcohol lamp was lit in a laminar flow hood, the mouth of the Erlenmeyer flask was burned, and the contents were poured into a petri dish. After the agar solidified, the flask was inverted and incubated at 37°C for 24 hours. After inoculating the bacterial strain at 37°C and 120 rpm for 24 hours, the bacterial suspension was collected, centrifuged at 7500 rpm for 5 minutes, the supernatant was discarded, and the bacterial concentration was controlled at 1 × 10⁻⁶. 8 CFU / mL. The sample was ultrasonically cleaned with anhydrous ethanol for 5 min, dried, and sterilized under ultraviolet light for 24 h before use. The prepared Pseudomonas aeruginosa suspension was evenly spread on a culture medium plate. The alloy was placed in the center of the plate and incubated at 37℃ for 24 h. The growth morphology of Pseudomonas aeruginosa and the size of the inhibition zone around the alloy were observed, and the antibacterial performance of the material was calculated using a formula:

[0079] B = (Dd) / 2

[0080] Where B represents the size of the inhibition zone blank area; D represents the diameter of the inhibition zone; and d represents the sample diameter in mm. When B ≥ 1 mm, the material exhibits good antibacterial properties; when B = 0 mm but no obvious colonies are observed around it, the material has antibacterial properties; and when B = 0 but obvious colonies are observed around it, the material exhibits poor antibacterial properties. A schematic diagram of the in vitro antibacterial experiment is shown below. Figure 4 As shown.

[0081] Biocompatibility testing: The MTT assay was used to detect the biocompatibility of the material. The sample was immersed in cell culture medium to prepare an extract. This extract was then used to culture rat small intestinal crypt epithelial cells (IEC-6). Cell growth was observed to evaluate the cytotoxicity of the material. According to ISO 10993-5:2009, the ratio of sample surface area to culture medium volume was 2 cm². 2Extraction solutions were prepared using a 3 mL extraction ratio. The extraction medium was 5% FBS high-glucose DMEM medium (containing 0.01 mg / mL insulin). The test materials were first ultrasonically cleaned with deionized water and anhydrous ethanol, dried, and then sterilized in centrifuge tubes containing anhydrous ethanol for 24 hours. They were then irradiated under UV light in a clean bench for 2 hours. The samples were then placed in centrifuge tubes containing a quantitative amount of cell culture medium and incubated in a 5% CO2, 37°C incubator for 24 hours to obtain the extract. IEC-6 cells were diluted with cell culture medium to a cell suspension of 10⁵ cells / mL. 96-well plates containing 100 μL of cell suspension in each well were incubated in a 37°C, 5% CO2 incubator for 24 hours. The original cell culture medium was then removed from the 96-well plates, and 100 μL of the extract was added to each well. Each experiment had 6 parallel experimental groups, with a negative control group consisting of complete cell culture medium. After 24 hours of culture, 10 μL of MTT (5 mg / mL) was added to each well of a 96-well plate and the plate was incubated for 4 hours. After 4 hours, the culture medium was removed from the 96-well plate, and 100 μL of DMSO solution was added. The absorbance was measured using a microplate reader at a UV wavelength of 550 nm. The measurements were repeated three times, and the average value was used to calculate the relative cell growth rate (RGR, %).

[0082]

[0083] The biocompatibility of materials is assessed according to ISO 10993-5:2009 standard: RGR value ≥100%, cytotoxicity grade 0, non-toxic; RGR value ≥80%, cytotoxicity grade 1, slightly toxic; RGR value 50%~80%, cytotoxicity grade 2, slightly toxic; RGR value ≤49%, cytotoxicity grade 3~4, unqualified.

[0084] Table 1 Performance of Examples and Comparative Examples

[0085]

[0086] Table 2. Simulated body fluid composition measured for degradation performance.

[0087] Element Content (g) purity NaCl 8.035 99.5﹪ <![CDATA[NaHCO3]]> 0.355 99.5﹪ KCl 0.225 99.5﹪ <![CDATA[K2HPO4·3H2O]]> 0.231 99﹪ <![CDATA[MgCl2·6H2O]]> 0.311 98﹪ c(HCl) = 1 mol / L 39mL <![CDATA[CaCl2]]> 0.292 95﹪ <![CDATA[Na2SO4]]> 0.072 99﹪ TRIS 6.118 99﹪ c(HCl) = 1 mol / L 0-5mL

Claims

1. A method for preparing a controllable degradable magnesium alloy material, characterized in that: Includes the following steps: Step 1, Cleaning: After removing the surface oxide film from pure magnesium and magnesium alloys, ultrasonic cleaning is performed. Step 2, Alloy Melting: Melt the pure magnesium and magnesium alloy cleaned in Step 1 under an inert atmosphere to obtain a molten alloy, and cool to obtain a cast magnesium alloy; Step 3, preparation of extruded alloy: First, the cast alloy obtained in Step 2 is subjected to homogenization heat treatment, and then extruded to obtain extruded magnesium alloy; Step 4, wire preparation: The extruded alloy obtained in Step 3 is annealed and then drawn in multiple passes to obtain magnesium alloy wire. Step 5, Ion Implantation: Cut the wire, grind and clean the wire, and perform copper ion implantation on a metal ion implanter equipped with a copper cathode arc source to obtain controllable degradable magnesium alloy material. The surface of the controllable degradable magnesium alloy material has a modified layer, which consists of a structural defect layer, a nano-fine grain layer, and a strain coarse grain layer from the surface inwards. In step five, the magnesium alloy wire implanted with copper ions is placed on the water-cooled target of the metal ion implanter. The ion implantation angle is 7~10°, the accelerating voltage is 40~50kV, and the vacuum chamber pressure is 2.0~6.0×10⁻⁶. -4 The implanted beam current is 1.0~2.0 mA; the copper ion implantation dose is 0.8~3×10⁻⁶. 17 ion / cm 2 .

2. The method for preparing controllable degradable magnesium alloy material according to claim 1, characterized in that: Step one involves removing the surface oxide film by acid washing with a phosphoric acid solution of 5-8% by volume.

3. The method for preparing controllable degradable magnesium alloy material according to claim 1, characterized in that: The extrusion temperature in step three is 200~250℃, the extrusion speed is 9-11mm / s, and the extrusion ratio is 54:1~64:

1.

4. The method for preparing controllable degradable magnesium alloy material according to claim 1, characterized in that: The magnesium alloy in step one is one or more of Mg-Zn alloy, Mg-Mn alloy and Mg-Zn-Mn alloy.

5. The method for preparing controllable degradable magnesium alloy material according to claim 4, characterized in that: The magnesium alloy has a Mg content of ≥98 wt.%.

6. The method for preparing controllable degradable magnesium alloy material according to claim 1, characterized in that: Step two is as follows: using an induction furnace and a graphite crucible under CO2 and SF6 protection, the magnesium alloy cleaned in step one is melted to obtain a molten alloy; the molten alloy is poured into a dry low-carbon steel mold with BN coating on the inner wall, and cooled to obtain a cast magnesium alloy.

7. The method for preparing controllable degradable magnesium alloy material according to claim 1, characterized in that: The thickness of the structural defect layer is 50~80nm; the thickness of the nanocrystalline layer is 550~620nm; and the thickness of the strained coarse-grained layer is 870~1430nm.

8. The method for preparing controllable degradable magnesium alloy material according to claim 1, characterized in that: The grain size of the structural defect layer is 500~580nm; the grain size of the nano-fine grain region is 250~300nm; and the grain size of the strained coarse grain region is 600~750nm.

9. The method for preparing controllable degradable magnesium alloy material according to claim 1, characterized in that: The annealing temperature in step four is 280-300℃.

Citation Information

Patent Citations

  • Magnesium alloy surface coating material and application thereof

    CN114481074A

  • Biodegradable antibacterial magnesium alloy anastomosis nail and preparation method thereof

    CN117018300A

  • Method for preparing antibacterial coating on surfaces of magnesium and magnesium alloy

    CN114369808A

  • Degradable pure magnesium or magnesium alloy surface modification method and pure magnesium or magnesium alloy material

    CN115522175A